13-Year Actuarial Rates of Any PCa Diagnosis and Clinically Significant PCa Diagnosis Based on Baseline PSA Measurements in Patients Aged 55 to 60 Years Enrolled in the Screening Group of the PLCO Cancer Screening Trial. Here, KLK3 is linked to cancer.